The Pathogenesis of AIDS Lymphomas: A Foundation for Addressing the Challeng of Therapy and Prevention

References

• Dalgleish A. G., Manca F, Habeshaw J. A. The pathogenesis of HIV-induced disease. AIDS and the New Viruses, A. G. Dalgleish, R. A Weiss. Academic Press, London 1991; 111
   Google Scholar
• Habeshaw J. A., Dalgleish A. G. The relevance of HIV env/CD4 interactions to the pathogenesis of acquired immune deficiency syndrome. J. AIDS. 1989; 2: 457
   PubMed Web of Science ®Google Scholar
• Manca F., Habeshaw J. A., Dalgleish A. G. HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4. Lancet 1990; 335: 811
   PubMed Web of Science ®Google Scholar
• Hoffmann G. W., Kion T. A., Grant M. D. An idiotypic network model of AIDS immunopathogenesis. Proc. Natl. Acad. Sci. USA 1991; 88: 3060
   PubMed Web of Science ®Google Scholar
• Kion T. A., Hoffmann G. W. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science 1991; 253: 1138
   PubMed Web of Science ®Google Scholar
• Imberti L., Sottini A., Bettinardi A., Puoti M., Primi D. Selective depletion in HIV infection of T cells that bear specific T cell receptor VB sequences. Science 1991; 254: 860
   PubMed Web of Science ®Google Scholar
• Berberian L., Valles-Ayoub Y., Sun N., Martinez-Maza O., Braun J. A VH clonal deficit in human immunodeficiency virus-positive individuals reflects a B-cell maturational arrest. Blood 1991; 78: 175
   PubMed Web of Science ®Google Scholar
• Braun J., Galbraith L., Valles-Ayoub Y., Saxon A. Human immunodeficiency resulting from maturational arrest of germinal center B cells. Immunol. Lett. 1991; 27: 205
   PubMed Web of Science ®Google Scholar
• Breen E. C., Rezai A. R., Nakajima K., Beall G. N., Matsuyasu R. T., Hirano T., Kishimoto T., Martinez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 1990; 144: 480
   PubMed Web of Science ®Google Scholar
• Laurence J., Astrin S. M. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proc. Natl. Acad. Sci. USA 1991; 88: 7635
   PubMed Web of Science ®Google Scholar
• Jeang K.-T., Widen S. C., Semmes O. J., IV, Wilson S. H. HTLV-1 trans-activator protein, Tax, is a trans-repressor of the human B-polymerase gene. Science 1990; 247: 1082
   PubMed Web of Science ®Google Scholar
• Cancer Statistics Review 1973-1988. National Cancer Institute, Division of Cancer Prevention and Control, NIH publication no. 91-2789, 1991
   Google Scholar
• Current trends. Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patienls surviving for prolonged periods on antiretroviral therapy-United States. MMWR 1991; 40: 591
   PubMedGoogle Scholar
• Knowles D. M., Chamulak G. A., Subar M., Burke J. S, Dugan M., Wernz J., Slywotzky C., Pelicci P.-G., Dalla-Favera R., Raphael B. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 1988; 108: 744
   PubMed Web of Science ®Google Scholar
• Pluda J. M., Yarchoan R., Jaffe E. S., Feuerstein I. M, Solomon D., Steinberg S. M., Wyvill K. M., Raubitschek A., Katz D., Broder S. Development of non-Hodgkin's lymphoma in a cohort of patients with severe immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann. Intern. Med. 1990; 113: 276
   PubMed Web of Science ®Google Scholar
• Ziegler J. L., Beckstead J. A., Volberding P. A., Abrams D. I., Levine A. M., Lukes R. J., Gill P. S., Burkes R. L., Meyer P. R., Metroka C. E., Mouradian J., Moore A., Riggs S. A, Butler J. J., Cabanillas Hersh E., Newell G. R., Laubenstein L. J., Knowles D., Odajnyk C., Raphael B., Koziner B., Urmacher C., Clarkson B. D. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N. Engl. J. Med. 1984; 211: 565
   Web of Science ®Google Scholar
• Beral V., Peterman T., Berkelman R., Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet 1991; 337: 805
   PubMed Web of Science ®Google Scholar
• Wilkes M. S., Fortin A. H., Felix J. C., Godwin T. A., Thompson W. G. Value of necropsy in acquired immunodeficiency syndrome. Lancet 1988; ii: 85
   Google Scholar
• Broder S., Mitsuya H., Yarchoan R., Pavlakis G. N. Antiretroviral therapy in AIDS. Ann. Intern. Med. 1990; 113: 604
   PubMed Web of Science ®Google Scholar
• Gail M. H., Pluda J. M., Rabkin C. S., Biggar R. J., Goedert J. J., Horm J. W., Sondik E. J., Yarchoan R., Broder S. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J. Natl. Cancer Inst. 1991; 83: 695
   PubMed Web of Science ®Google Scholar
• Yarchoan R., Pluda J. M., Perno C.-F., Mitsuya H., Broder S. Anti-retroviral therapy of HIV infection: current strategies and challenges for the future. Blood 1991; 78: 859
   PubMed Web of Science ®Google Scholar
• McKinney R. E., Maha M. A., Connor E. M. A multicenter trial of oral zidovuding in children with advanced human immunodeficiency virus disease. N. Engl. J. Med. 1991; 324: 1018
   PubMed Web of Science ®Google Scholar
• Moore R. D., Hidalgo J., Sugland B. W., Chaisson R. E. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N. Engl. J. Med. 1991; 324: 1412
   PubMed Web of Science ®Google Scholar
• Yarchoan R., Venzon D. J., Pluda J. M., Lietzau J., Wyvill K. M., Tsiatis A. A., Steinberg S. M., Broder S. CD4 count as a mortality risk indicator in human immunodeficiency virus (HIV)-infected patients receiving antiretroviral therapy: experience in a research hospital. Ann Intern. Med. 1991; 115: 184
   PubMed Web of Science ®Google Scholar
• Rosenberg P. S., Gail M. H., Schrager L. K., Vermund S. H., Creagh-Kirk T., Andrews E. B., Winkelstein W., Marmor M., Des Jarlais D. C., Biggar R. J., Goedert J. J. National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups. J. AIDS 1991; 4: 392
   PubMed Web of Science ®Google Scholar
• Gill P. S., Levine A. M., Meyer P. R., Boswell W. D., Burkes R. L., Parker J. W., Hofman F. M., Dworsky R. L., Lukes R. J. Primary central nervous system lymphoma in homosexual men. Clinical, immunologic and pathologic features. Am. J. Med. 1985; 78: 742
   PubMed Web of Science ®Google Scholar
• Moore R. D., Kessler H., Richman D. D., Flexner C., Chaisson R. E. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine. JAMA 1991; 265: 2208
   PubMed Web of Science ®Google Scholar
• Pluda J. M, Venzon D., Tosato G., Lietzau J., Wyvill K., Nelson D., Karp J., Broder S., Yarchoan R. The development of opportunistic non-Hodgkin's lymphomas (NHL) in patients receiving long-term antiretroviral therapy (abstract). Proc. Amer. Soc. Clin. Oncol 1992, submitted
   Google Scholar
• Gamier G., Taillan B., Michiels J. F. HIV-associated Hodgkin's disease. Ann. Intern. Med. 1991; 115: 233
   Web of Science ®Google Scholar
• World Health Organization, Geneva. Acquired immunodeficiency syndrome (AIDS) surveillance update to 31 December 1988 in the WHO European region. Weekly Epidemiological Record 1989; 64: 109
   Google Scholar
• Monfardini S., Tirelli U., Vaccher E., Foa R., Gavosto F. Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Ann. Oncol. 1991; 2, (Suppl.), 201
   Web of Science ®Google Scholar
• Ames E. D., Conjakla M. S., Goldberg A. F., Hirschman R., Jain S., Distenfeld A., Metroka C. E. Hodgkin's disease and AIDS. Hemalol. Oncol. Clin. N. Amer. 1991; 5: 343
   PubMedGoogle Scholar
• Gold J. E., Altarac D., Ree H. J., Khan A., Sodillo P. P., Zalusky R. HIV-associated Hodgkin disease: a clinical study of 18 cases and review of the literature. Am. J. Hematol 1991; 36: 93
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Korsmeyer S. J., Bakhshi A., Arnold A., Kirsch I. R. Molecular genetic analysis of human lymphoid neoplasms. Immunoglobulin genes and the c-my oncogene. Ann. Intern. Med. 1985; 102: 497
   PubMed Web of Science ®Google Scholar
• Croce C. M., Nowell P. C. Molecular basis of human B cell neoplasia. Blood 1985; 65: 1
   PubMed Web of Science ®Google Scholar
• Haluska F. G., Tsujimoto Y., Croce C. M. Mechanisms of chromosome translocation in B- and T-cell neoplasia. Trends in Genetics 1987; 3: 11
   Web of Science ®Google Scholar
• Schouten H. C., Sanger W. G., Weisenburger D. D., Anderson J., Armitage J. O. Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. Blood 1990; 75: 1841
   Google Scholar
• Yunis J. J., Oken M. M., Kaplan M. E., Ensrud K. M., Howe R. R., Theologides A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N. Engl. J. Med. 1982; 307: 1231
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R. C., Croce C. M. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 1982; 79: 7824
   PubMed Web of Science ®Google Scholar
• Ladanyi M., Offitt K., Jhanwar S. C., Filippa D. A., Chaganti R. S. K. MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood 1991; 77: 1057
   PubMed Web of Science ®Google Scholar
• Pellici P. G., Knowles D. M., Magrath I., Dalla-Favera R. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 1986; 83: 2984
   PubMed Web of Science ®Google Scholar
• Shiramizu B., Barriga F., Neequaye J., Jafri A., Dalla-Favera R., Neri A., Guttierez M., Levine P., Magrath I. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991; 77: 1516
   PubMed Web of Science ®Google Scholar
• Klein G. Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors. Genes Chromosomes Cancer 1989; 1: 3
   PubMed Web of Science ®Google Scholar
• Gauwerky C. E., Croce C. M. Molecular biology of leukemias and lymphomas. Molecular Foundations of Oncology, S. Broder. Williams and Wilkins, Baltimore, Md 1991; 295
   Google Scholar
• Lombardi L., Grignani F., Sternas L., Cechova K., Inghirami G., Dalla-Favera R. Mechanism of negative feed-back regulation of c-myc gene expression in B-cells and its inactivation in tumor cells. Curr. Topics Microbiol. Immunol. 1990; 166: 295
   Google Scholar
• Gregory C. D., Dive C., Henderson S., Smith C. A., Williams G. T., Gordon J., Rickinson A. B. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991; 349: 612
   PubMed Web of Science ®Google Scholar
• Calender A., Cordier M., Billaud M., Lenoir G. M. Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV). Inter. J. Cancer 1990; 46: 658
   PubMed Web of Science ®Google Scholar
• Kumar A., Rogers T., Maizel A., Sharma S. Loss of transforming growth factor B1 receptors and its effects on the growth of EBV-transformed human B cells. J. Immunol. 1991; 147: 998
   PubMed Web of Science ®Google Scholar
• Go N. F., Castle B. E., Barrett R., Kastelein R., Dang W., Mosmann T. R., Moore K. W., Howard M. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exper. Med 1990; 172: 1625
   PubMed Web of Science ®Google Scholar
• Hsu D.-H., Malefyt R. D., Fiorentino D. F., Dang M.-N., Vieira P., De Vries J., Spits H., Mosmann T. R., Moore K. W. Expression of Interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1990; 250: 830
   PubMed Web of Science ®Google Scholar
• Moore K. W., Vieira P., Fiorentino D. F., Trounstine M. L., Khan T. A., Mosmann T. R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 1990; 248: 1230
   PubMed Web of Science ®Google Scholar
• Billaud M., Rousset F., Calender A., Cordier M., Aubry J.-P., Laisse V., Lenoir G. M. Low expression of lymphocyte function-associated antigen (LFA)-l and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus. Blood 1990; 75: 1827
   PubMed Web of Science ®Google Scholar
• Gregory C. D., Murray R. J., Edwards C. F., Rickinson A. B. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J. Exper. Med. 1988; 167: 1811
   PubMed Web of Science ®Google Scholar
• Inghirami G., Grignani F., Sternas L., Lombardi L., Knowles D. M., Dalla-Favera R. Down-regulation of LFA-1 adhesion receptors by c-myc oncogene in human B lymphoblastoid cells. Scioence 1990; 250: 682
   PubMed Web of Science ®Google Scholar
• Lombardi L., Newcomb E. W., Dalla-Favera R. Pathogenesis of Burkitt lymphomas: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 1987; 49: 161
   PubMed Web of Science ®Google Scholar
• Antin J. H., Bierer B. E., Smith B. R., Ferrara J., Guinan E. C., Sieff C., Golan D. E., Macklis R. M., Tarbell N. J., Lynch E., Reichert T. A., Blythman H., Bouloux C., Rappeport J. M., Burakoff S. J., Weinstein H. J. Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies. Blood 1991; 78: 2139
   PubMed Web of Science ®Google Scholar
• Hanto D. W., Frizzera G., Gajl-Peczalska K. J., Sakamoto K., Purtilo D. T., Balfour H. H., Simmons R. L., Najarian J. S. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N. Engl. J. Med. 1982; 306: 913
   PubMed Web of Science ®Google Scholar
• Hochberg F. H., Miller G., Schooley R. T., Hirsch M. S., Feorino P., Henle W. Central-nervous-system lymphoma related to Epstein-Barr virus. N. Engl. J. Med. 1983; 309: 745
   PubMed Web of Science ®Google Scholar
• Shearer W. T., Ritz J., Finegold M. J., Guerra I. C., Rosenblatt H. M., Lewis D. E., Pollack M. S., Taber L. H., Sumaya C. V., Grumet F. C., Cleary M. L., Warnke R., Sklar J. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N. Engl. J. Med. 1985; 312: 1151
   PubMed Web of Science ®Google Scholar
• Brousset P., Chittal S., Schlaifer D., Icart J., Payen C., Rigal-Huguet F., Voight J.-J., Delsol G. Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections. Blood 1991; 77: 1781
   PubMed Web of Science ®Google Scholar
• Knecht H., Odermatt B. F., Bachmann E., Teixeira S., Sahli R., Hayoz D., Heitz P., Bachmann F. Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without genomic evidence of B- or T-cell clonality. Blood 1991; 78: 760
   PubMed Web of Science ®Google Scholar
• Herbst H., Dallenbach F., Hummel M, Niedobitek G., Finn T., Young L. S., Rowe M., Muller-Lantzsch N., Stein H. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. Blood 1991; 78: 2666
   PubMed Web of Science ®Google Scholar
• Doglioni C., Pelosio P., Mombello A., Scarpa A., Chilosi M. Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas. Hematol. Pathol. 1991; 5: 67
   Web of Science ®Google Scholar
• Jornvall H., Luka J., Klein G., Appella E. A 53-kilodalton protein common to chemically and virally transformed cells shows extensive sequence similarities between species. Proc. Natl. Acad. Set. USA 1982; 79: 287
   PubMed Web of Science ®Google Scholar
• Luka J., Jornvall H., Klein G. Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit. J. Virol. 1980; 35: 592
   PubMed Web of Science ®Google Scholar
• Dyson N., Howley P. M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 248: 934
   Web of Science ®Google Scholar
• Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76
   PubMed Web of Science ®Google Scholar
• Cremer K. J., Spring S. B., Gruber J. Role of human immunodeficiency virus type I and other viruses in malignancies associated with acquired immunodeficiency disease syndrome. J. Natl. Cancer Inst. 1990; 82: 1016
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S. J., Pallesen G., Karkov J., Skinhoj P., Franzmann M. B., Pedersen C. Identification of EBV-DNA in tumour cells of AIDS-related lymphomas by in-situ hybridisation. Lancet 1989; i: 554
   Google Scholar
• Meeker T. C., Shiramizu B., Kaplan L., Herndier B., Sanchez H., Grimaldi J. C., Baumgartner J., Rachlin J., Feigal E., Rosenblum M., McGrath M. S. Evidence for molecular subtypes of HIV-associated lymphoma: division into peripheral monoclonal, polyclonal and central nervous system lymphoma. AIDS 1991; 5: 669
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Nalensik M. A., Shearer W. T., Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988; 72: 349
   PubMed Web of Science ®Google Scholar
• Neri A., Barriga F., Inghirami G., Knowles D. M., Neequaye J., Magrath I. T., Dalla-Favera R. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphomas. Blood 1991; 77: 1092
   PubMed Web of Science ®Google Scholar
• Shibata D., Weiss L. M., Nathwani B. N., Brynes R. K., Levine A. M. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 1991; 77: 1527
   PubMed Web of Science ®Google Scholar
• Groopman J. E., Sullivan J., Mulder C., Ginsburg D., Orkin S. H., O'Hara C. J., Falchuk K., Wong-Staal F., Gallo R. C. Pathogenesis of B cell lymphoma in a patient with AIDS. Blood 1986; 67: 612
   PubMed Web of Science ®Google Scholar
• Knowles D. M., Inghirami G., Ubriaco A., Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 1989; 73: 792
   PubMed Web of Science ®Google Scholar
• Subar M., Neri A., Inghirami G., Knowles D. M., Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988; 72: 667
   PubMed Web of Science ®Google Scholar
• Stanbridge E. J., Nowell P. C. Origins of human cancer revisited. Cell 1990; 63: 867
   PubMed Web of Science ®Google Scholar
• Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature 1987; 329: 219
   PubMed Web of Science ®Google Scholar
• Gaidano G., Ballerini P., Gong J. Z., Inghirami G., Neri A., Newcomb E. W., Magrath I. T., Knowles D. M., Dalla-Favera R. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 5413
   PubMed Web of Science ®Google Scholar
• Hollingsworth R. E., Lee W.-H. Tumor suppressor genes: new prospects for cancer research. J. Natl. Cancer Inst. 1991; 83: 91
   PubMed Web of Science ®Google Scholar
• Wilcock D., Lane D. P. Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. Nature 1991; 349, 429, 1991
   PubMed Web of Science ®Google Scholar
• Decaprio J. A., Ludlow J. W., Lynch D., Furukawa Y., Griffin J., Piwnica-Worms H., Huang C.-M., Livingston D. M. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989; 58: 1085
   PubMed Web of Science ®Google Scholar
• Birx D. L., Redfield R. R., Tencer K., Fowler A., Burke D. S., Tosato G. Induction of Interleukin-6 during human immunodeficiency virus infection. Blood 1990; 76: 2303
   PubMed Web of Science ®Google Scholar
• Scadden D. T., Zeira M., Woon A., Wang Z., Schieve L., Ikeuchi K., Lim B., Groopman J. E. Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 1990; 76: 317
   PubMed Web of Science ®Google Scholar
• Hirano T. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias. Inter. J. Cell Cloning 1991; 9: 166
   PubMedGoogle Scholar
• Kishimoto T. The biology of Interleukin-6. Blood 1989; 74: 1
   PubMed Web of Science ®Google Scholar
• Birx D. L., Redfield R. R., Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N. Engl. J. Med. 1986; 314: 874
   PubMed Web of Science ®Google Scholar
• Yarchoan R., Redfield R. R., Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. J. Clin. Invest. 1986; 78: 439
   PubMed Web of Science ®Google Scholar
• Schwab G., Siegall C. B., Aarden L. A., Neckers L. M., Nordan R. P. Characterization of an Interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line U266. Blood 1991; 11: 587
   Google Scholar
• Zhang X. G., Klein B., Bataille R. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 1989; 74: 11
   PubMed Web of Science ®Google Scholar
• Miles S. A., Rezai A. R., Salazar-Gonzalez J. F., Vander Myeden M., Stevens R. H., Logan D. M., Mitsuyasu R. T., Taga T., Hirano T., Kishimoto T., Martinez-Maza O. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 1990; 87: 4068
   PubMed Web of Science ®Google Scholar
• Yonisch-Rouach E., Resnsitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345
   PubMed Web of Science ®Google Scholar
• Paul W. E. Interleukin-4: a prototype immunoregulatory lymphokine. Blood 1991; 11: 1859
   Google Scholar
• Golumbek P. T., Lazenby A. J., Levitsky H. I., Jaffee L. M, Karasuyama H., Baker M., Pardoll D. M. Treatment of established renal cancer by tumor cells engineered to secrete Interleukin-4. Science 1991; 254: 713
   PubMed Web of Science ®Google Scholar
• Tepper R. I., Pattengale P. K., Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989; 57: 503
   PubMed Web of Science ®Google Scholar
• Te Velde A. A., Huijbens R. J. F., Heije K., De Vries J. E., Figdor C. G. Interleukin-4 (IL-4) inhibits secretion of IL-lb, tumors necrosis factor-a, and IL-6 by human monocytes. Blood 1990; 76: 1392
   PubMed Web of Science ®Google Scholar
• Herrmann F., Andreeff M., Gruss H.-J., LÜBbert M., Mertelsmann R. Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression. Blood 1991; 78: 2070
   PubMed Web of Science ®Google Scholar
• Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M, Moore K. W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991; 146: 3444
   PubMed Web of Science ®Google Scholar
• Salgame P., Abrams J. S., Clayberger C., Goldstein H., Convit J, Modlin R. L., Bloom B. R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279
   PubMed Web of Science ®Google Scholar
• Yamamura M, Uyemura K., Deans R. J., Weinberg K., Rea T. H., Bloom B. R., Modlin R. L. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277
   PubMed Web of Science ®Google Scholar
• Heinzel F. P., Sadick M. D., Mutha S. S., Locksley R. M. Production of interferon-gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Nail. Acad. Sci. U.S.A. 1991; 88: 7011
   PubMed Web of Science ®Google Scholar
• Chen W.-F., Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 1991; 147: 528
   PubMed Web of Science ®Google Scholar
• Kamel-Reid S., Dick J. E. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988; 242: 1706
   PubMed Web of Science ®Google Scholar
• McCune J. M., Namikawa R., Kaneshima H., Shultz L. D., Lieberman M., Weissman I. L. The SCID-hu mouse: murine model for the analysis of human hemato-lymphoid differentiation and function. Science 1988; 241: 1632
   PubMed Web of Science ®Google Scholar
• Mosier D. E., Gulizia R. J., Baird S. M., Wilson D. B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256
   PubMed Web of Science ®Google Scholar
• Lubin I., Faktorowich Y., Lapidot T., Gan Y., Eshhar Z., Gazit E., Levite M., Reisner Y. Engraftment and development of human T and B cells in mice after bone marrow transplantation. Science 1991; 252: 427
   PubMed Web of Science ®Google Scholar
• Cannon M. J., Pisa P., Fox R. I., Cooper N. R. Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J. Clin. Invest. 1990; 85: 1333
   PubMed Web of Science ®Google Scholar
• Rowe M., Young L. S., Crocker J., Stokes H., Henderson S., Rickinson A. B. Epstein-Barr Virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J. Exper. Med. 1991; 173: 147
   PubMed Web of Science ®Google Scholar
• Schuler W., Ruetsch N. R., Amsler M., Bosma M. J. Coding joint formation of endogenous T cell receptor genes in lymphoid cells from scid mice: unusual P-nucleotide additions in VJ-coding joints. Europ. J. Immunol. 1991; 21: 589
   PubMed Web of Science ®Google Scholar
• Schwarz K., Hansen-Hagge T. E., Friedrich W., Kleihauer E., Bartram C. R. Severe combined immunodeficiency (B-SCID) patients show an altered recombination pattern at the JH locus. Progress in Immune Deficiency III, H. M. Chapel, R. J. Levinsky, A. D. B Webster. Royal Society of Medicine Services Limited. 1991; 159
   Google Scholar
• Harris C. C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res. 1991; 51: 5023s
   PubMed Web of Science ®Google Scholar
• Taylor A. M. R., Metcalfe J. A., McConville C. Increased radiosensitivity and the basic defect in ataxia telangiectasia. Int. J. Radial. Biol. 1989; 56: 677
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Misiti J., Nelson D. L., Kraemer K. H. Ataxiatelangiectasia: a multisystem hereditary disease with immunodeficiency, impaired organ maturation, x-ray hypersensitivity, and a high incidence of neoplasia. Ann. Intern. Med. 1983; 99: 367
   PubMed Web of Science ®Google Scholar
• Epstein R. J. Drug-induced DNA damage and tumor chemosensitivity. J. Clin. Oncol. 1990; 8: 2062
   PubMed Web of Science ®Google Scholar
• Hecht F., Hecht B. K. M. Chromosome changes connect immunodeficiency and cancer in ataxia-telangiectasia. Amer. Pediatr. Hematol. Oncol. 1987; 9: 185
   Web of Science ®Google Scholar
• Davey M. P., Bertness V., Nakahara K., Johnson J. P., McBride O. W., Waldmann T. A., Kirsch I. R. Juxtaposition of the T-cell receptor α-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 1988; 14, 14 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia. Proc. Natl. Acad. Sci. U.S.A.; 85:9287
   Google Scholar
• Lipkowitz S., Stern M.-H., Kirsch I. R. Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasia lymphocytes. J. Exper. Med. 1990; 172: 409
   PubMed Web of Science ®Google Scholar
• Waldmann T. A. The arrangement of immunoglobulin and T-cell receptor genes in human lymphoproliferative disorders. Adv. Immunol 1987; 40: 247
   PubMed Web of Science ®Google Scholar
• Russo G., Isobe M., Gatti R., Finan J., Batuman O., Huebner K., Nowell P. C., Croce C. M. Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 602
   PubMed Web of Science ®Google Scholar
• Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Ca. Res. 1991; 51: 6304
   PubMed Web of Science ®Google Scholar
• Valerie K., Defers A., Bruck C., Thiriart C., Rosenberg H., Debouck C., Rosenberg M. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature 1988; 333: 78
   PubMed Web of Science ®Google Scholar
• Valerie K., Rosenberg M. Chromatin structure implicated in activation of HIV-1 gene expression by ultraviolet light. New Biologist 1990; 2: 712
   PubMedGoogle Scholar
• Zmudzka B. Z., Beer J. Z. Activation of human immunodeficiency virus by ultraviolet radiation. Photochem. Photobio 1990; 152: 1153
   Web of Science ®Google Scholar
• Beecham E. J., Mushinski F., Shacter E., Potter M., Bohr V. A. DNA repair in the c-myc proto-oncogene locus: possible involvement in susceptibility or resistance to plasmacytoma induction in BALB/c mice. Mol. Cell Biol 1991; 11: 3095
   PubMed Web of Science ®Google Scholar
• Feichtinger H., Putkonen P., Parravicini C., Li S.-L., Kaaya E. E., Bottiger D., Biberfeld G., Biberfeld P. Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. Amer. J. Pathol. 1990; 137: 1311
   PubMed Web of Science ®Google Scholar
• Klein G., Pearson G., Rabson A., Ablashi D. V., Falk L., Wolfe L., Deinhardt F., Rabin H. Antibody reactions to Herpesvirus Saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys. Int. J. Cancer 1973; 12: 270
   PubMed Web of Science ®Google Scholar
• Dolin R., Rabson A. S. Enhancement of adenovirus-associated virus. J. Natl. Cancer Inst. 1973; 50: 205
   PubMed Web of Science ®Google Scholar
• Bohannon R. C., Donehower L. A., Ford R. J. Isolation of a type D retrovirus from B-cell lymphoma of a patient with AIDS. J. Virol 1991; 65: 5663
   PubMed Web of Science ®Google Scholar
• Penn I. Tumors arising in organ transplant recipients. Adv. Cancer Res. 1978; 28: 31
   PubMedGoogle Scholar
• Longo D. L., Devita V. T., Duffey P. L., Wesley M. N., Ihde D. C., Hubbard S. M., Gilliom M, Jaffe E. S., Cossman J., Fisher R. I., Young R. C. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. J. Clin. Oncol. 1991; 9: 25
   PubMed Web of Science ®Google Scholar
• Raphael B. G., Knowles D. M. Acquired Immunodeficiency Syndrome-associated non-Hodgkin's lymphoma. Semin. Oncol. 1990; 17: 361
   PubMed Web of Science ®Google Scholar
• Kaplan L. D., Kahn J. O., Crowe S., Northfelt D., Neville P., Grossberg H., Abrams D. I., Tracey J., Mills J., Volberding P. A. Clinical and virologic effects of recombinant granulocyte-macrophage colony stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. J. Clin. Oncol., 9: 929
   PubMed Web of Science ®Google Scholar
• Perno C. F., Cooney D. A., Currens M. J., Rocchi G., Johns D. G., Broder S., Yarchoan S. Ability of anti-HIV agents to inhibit HIV replication in monocyte/macrophages or U937 monocytoid cells under conditions of enhancement by GM-CSF or anti-HIV antibody. AIDS RES Human Retrovir. 1990; 6: 1051
   PubMed Web of Science ®Google Scholar
• Pluda J. M, Yarchoan R., Smith P. D., McAtee N., Shay L. E., Oette D., Maha M, Wahl S. M., Myers C. E., Broder S. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. Blood 1990; 76: 463
   PubMed Web of Science ®Google Scholar
• Schuitemaker H., Kootstra N. A., Van Oers M. H. J., Van Lambalgen R., Tersmette M., Miedema F. Induction of monocyte proliferation and HIV expression by IL-3 does not interfere with anti-viral activity a Zidovudine. Blood 1990; 76: 1490
   PubMed Web of Science ®Google Scholar
• McMaster M. L., Greer J. P., Greco F. A., Johnson D. H., Wolff S. N., Hainsworth J. D. Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy. J. Clin. Oncol. 1991; 9: 941
   PubMed Web of Science ®Google Scholar
• Holland H. K., Saral R., Rossi J. J., Donnenberg A. D., Burns W. H., Beschorner W. E., Farzadegan H., Jones R. J., Quinnan G. V., Vogelsang G. B., Vriesendorp H. M., Wingard J. R., Zaia J. A., Santos G. W. Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin's lymphoma. Ann. Intern. Med. 1989; III: 973
   Google Scholar
• Sidell N., Taga T., Hirano T., Kishimoto T., Saxon A. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J. Immunol 1991; 146: 3809
   PubMed Web of Science ®Google Scholar
• Bonhomme L., Fredj G., Averous S., Szekely A. M., Ecstein E., Trumbie B., Meyer P., Lang J. M., Misset J L., Jasmin C. Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid (Letter to the). Ann. Oncol 1991; 2: 234
   PubMed Web of Science ®Google Scholar
• Fazely F., Dezube B. J., Allen-Ryan J., Pardee A. B., Ruprecht R. M. Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type I in human peripheral blood mononuclear cells and in cultured T cells. Blood 1991; 11: 1653
   Google Scholar
• Stein C. A., Ranajit P., Devico A. L., Hoke G., Mumbauer S., Kinstler O., Sarngadharan M. G., Letsinger R. L. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxy-nucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro. Biochemistry 1991; 30: 2439
   PubMed Web of Science ®Google Scholar
• Sullenger B. A., Gallardo H. F., Lingers G. E., Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell. 1990; 63: 601
   PubMed Web of Science ®Google Scholar
• McManaway M. E., Neckers L. M., Loke S. L., Al-Nasser A. A., Redner R. L., Shiramizu B. T., Golschmidts W. L., Huber B. E., Bhatia K., Magrath I. T. Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet 1990; 335: 808
   PubMed Web of Science ®Google Scholar
• Reed J. C., Stein C., Subasinghe C., Haldar S., Croce C. M., Yum S., Cohen J. Antisense-mediated inhibition of BCL-2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res. 1990; 50: 6565
   PubMed Web of Science ®Google Scholar
• Szczylik C., Skorski T., Nicolaides N. C., Manzella L., Malaguarnera L., Venturelli D., Gerwitz A. M., Calabretta B. Selective inhibition of leukemic cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science 1991; 253: 562
   PubMed Web of Science ®Google Scholar
• Riordan M. L., Martin J. C. Oligonucleotide-based therapeutics. Nature 1991; 350: 442
   Web of Science ®Google Scholar